HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$0.50
Day range
$0.47 - $0.49
Year range
$0.34 - $3.67
Market cap
41.66M USD
Avg Volume
500.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.17M | 1,457.09% |
Operating expense | 9.11M | 6.08% |
Net income | -36.07M | 8.44% |
Net profit margin | -864.44 | 94.12% |
Earnings per share | -0.35 | 22.61% |
EBITDA | -31.00M | -14.52% |
Effective tax rate | -5.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 189.29M | 9.58% |
Total assets | 353.22M | -2.07% |
Total liabilities | 191.85M | 9.04% |
Total equity | 161.36M | — |
Shares outstanding | 86.05M | — |
Price to book | 0.27 | — |
Return on assets | -23.13% | — |
Return on capital | -36.86% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -36.07M | 8.44% |
Cash from operations | -24.22M | 7.65% |
Cash from investing | 30.61M | 64.52% |
Cash from financing | -602.00K | -69.10% |
Net change in cash | 5.78M | 172.42% |
Free cash flow | 96.37M | 737.28% |
About
Founded
2018
Headquarters
Website
Employees
140
